(SACRAMENTO) A UC Davis Health team has developed a first-of-its-kind positron emission tomography (PET) scan imaging-based tool to detect liver inflammation in…
Browsing: Hot headlines in GI
There’s good news for bread lovers who have irritable bowel syndrome. It turns out high consumption of gluten doesn’t lead…
The choice of general anesthetic regimen—either total intravenous anesthesia (TIVA) or volatile anesthesia—does not appear to affect cancer outcomes after…
Inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis, are chronic, progressive, immune-mediated diseases of adults and children that…
In May 2021, the Centers for Medicare and Medicaid Services (CMS) Quality Measures Voting Members unanimously recommended the addition of…
Scrubs & Heels, a new initiative created by women for women in the field of gastroenterology, aims to empower women…
Medical device and technology company Lazurite Holdings LLC has been recognized by MedTech Outlook magazine as a 2021 Top 10…
Results from a double-blind, randomized OPT-PEACE trial showed that almost all patients (at low bleeding risk) who received antiplatelet therapy…
According to the hospital, the most effective treatment for metastatic colorectal cancer is targeted therapy and chemotherapy, which block only…
By Landon Gray Originally published in our sister publication, Gastroenterology & Endoscopy News Phathom announced the FDA approval of vonoprazan tablets, amoxicillin capsules, clarithromycin tablets (Voquezna Triple PAK, Phathom)…